Julie Malo is a clinical research nurse and clinical-administrative coordinator in Dr. Bertrand Routy’s laboratory at the Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM). She has worked in clinical research for the past 10 years, following a diverse clinical career in hospitals across Quebec and Ontario, including experience in emergency and frontline care. In her current role, she supports and coordinates clinical research focused on the microbiome and cancer immunotherapy. She is part of the CHUM team that partnered with Segata Lab, Zitvogel/Kroemer and Western University on the phase 2 FMT-LUMINate trial testing fecal microbiota transplantation combined with immune checkpoint inhibitors in melanoma and non-small cell lung cancer (Nat Med, 2026). Her work encompasses clinical trial coordination, patient recruitment, biobank and biospecimen management, research operations, and the implementation of microbiome-focused research within cancer immunotherapy programs.